GL1X · GenesisL1 explorer

Research workbench

Small molecule inhibitors of the ledgf site of HIV type 1 integrase identified by fragment screening and structure based drug design

Analyse Small molecule inhibitors of the ledgf site of HIV type 1 integrase identified… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ZSQ
Type
protein
Length
298 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrase
EC
2.7.7.-
UniProt
Q76353
Ligands
O4N, SO4
Pockets
7 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 53% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BIntegrase (EC 2.7.7.-)protein14953% helix, 21% strandQ76353

Ligands and binding sites

  • O4N · 5-[[[2-[[(1S)-1-(4-methoxyphenyl)butyl]carbamoyl]phenyl]methyl-prop-2-enyl-amino]methyl]-1,3-benzodioxole-4-carboxylic acid · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 4 copies · chains A, B
  • ACY · Acetic acid · additive · 3 copies · chains A, B
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12480.650.8233ACY
21120.520.8125empty
3950.500.8221empty
41840.470.7535empty
51490.420.7527empty

Interfaces

1 interface between chains.

  • A–B · 1481 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 3ZSQ · Small molecule inhibitors of the LEDGF site of HIV type 1 integrase identified by… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.